Search

Your search keyword '"Piras, Daniela"' showing total 114 results

Search Constraints

Start Over You searched for: Author "Piras, Daniela" Remove constraint Author: "Piras, Daniela"
114 results on '"Piras, Daniela"'

Search Results

2. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study

3. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

4. Prevalence and indicators of cure of Italian women with vulvar squamous cell carcinoma: A population-based study

5. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study

6. Indicators of cure for women living after uterine and ovarian cancers: a population-based study

7. Prevalence and Indicators of Cure of Italian Women with Vulvar Squamous Cell Carcinoma

8. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

9. Trends in Net Survival from Vulvar Squamous Cell Carcinoma in Italy (1990–2015)

10. Dynamic Simulations of Pathways Downstream of TGFβ, Wnt and EGF-Family Growth Factors, in Colorectal Cancer, including Mutations and Treatments with Onco-Protein Inhibitors

11. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study

12. Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype

13. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries

14. Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes

15. Fruit Beer with the Bisucciu Sardinian Apricot Cultivar (Prunus armeniaca L.): A Technological and Analytical Approach.

19. Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study

20. Dynamic Simulations of Pathways Downstream of TGFβ, Wnt and EGF-Family Growth Factors, in Colorectal Cancer, including Mutations and Treatments with Onco-Protein Inhibitors

22. A new essential hypertension susceptibility locus on chromosome 2p24-p25, detected by genomewide search

23. Mid‐term trends and recent birth‐cohort‐dependent changes in incidence rates of cutaneous malignant melanoma in Italy

24. Who were the Karians in Hellenistic times? The evidence from epichoric language and personal names

25. Hellenistic Karia

27. Genetic variants involved in Blood Pressure response to hydrochlorothiazide identified by GWAS methodology

28. A Functional 12T-insertion polymorphism in the ATP1A1 promoter confers decreased susceptibility to hypertension in a male Sardinian population

29. Solid-phase synthesis of conformationally constrained peptidomimetics based on a 3,6-disubstituted-1,4-diazepan-2,5-dione core

30. Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer

33. Transcription Factors Synergistically Activated at the Crossing of the Restriction Point between G1 and S Cell Cycle Phases. Pathologic Gate Opening during Multi-Hit Malignant Transformation

35. TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives

36. A Functional 12T-Insertion Polymorphism in the ATP1A1 Promoter Confers Decreased Susceptibility to Hypertension in a Male Sardinian Population

37. [New incidence and mortality data. 2003-2005]

39. Abstract 2116: CHEK2 (Chk2) endogenous activation is associated with p53 deficiency and downregulation of BRCA2 and Fanconi Anemia pathway gene members in the National Cancer Institute Anticancer Tumor Cell Line Panel (NCI-60)

40. Haplotype Affinities Resolve a Major Component of Goat (Capra hircus) MtDNA D-Loop Diversity and Reveal Specific Features of the Sardinian Stock

42. ChemInform Abstract: 1,8‐Naphthyridines. Part 8. Novel 5‐Aminoimidazo[1,2‐a][1,8]naphthyridine‐6‐carboxamide and 5‐Amino[1,2,4]triazolo[4,3‐a][1,8]naphthyridine‐6‐carboxamide Derivatives Showing Potent Analgesic or Antiinflammatory Activity, Respectively, and Completely Devoid of Acute Gastrolesivity.

44. 1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity

48. Synthesis and In Vitro Antiplatelet Activity of New 4-(1-Piperazinyl)coumarin Derivatives. Human Platelet Phosphodiesterase 3 Inhibitory Properties of the Two Most Effective Compounds Described and Molecular Modeling Study on Their Interactions with Phosphodiesterase 3A Catalytic Site

49. Trends in Net Survival from Vulvar Squamous Cell Carcinoma in Italy (1990–2015)

50. TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives

Catalog

Books, media, physical & digital resources